These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8462410)

  • 41. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes.
    Chasnoff IJ; McGourty RF; Bailey GW; Hutchins E; Lightfoot SO; Pawson LL; Fahey C; May B; Brodie P; McCulley L; Campbell J
    J Perinatol; 2005 Jun; 25(6):368-74. PubMed ID: 15703775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal characteristics and pregnancy outcomes among illicit drug-using women in an urban setting.
    Homsup P; Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):83-88. PubMed ID: 29458910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.
    Lendoiro E; González-Colmenero E; Concheiro-Guisán A; de Castro A; Cruz A; López-Rivadulla M; Concheiro M
    Ther Drug Monit; 2013 Jun; 35(3):296-304. PubMed ID: 23666580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Illicit drug use before and during pregnancy at a tertiary maternity hospital 2000-2006.
    Hayatbakhsh MR; Kingsbury AM; Flenady V; Gilshenan KS; Hutchinson DM; Najman JM
    Drug Alcohol Rev; 2011 Mar; 30(2):181-7. PubMed ID: 21355910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increasing the recognition of barriers for pregnant substance users seeking treatment.
    Shannon L; Walker R
    Subst Use Misuse; 2008 Jul; 43(8-9):1266-7. PubMed ID: 18649244
    [No Abstract]   [Full Text] [Related]  

  • 47. Retention in substance abuse treatment. Role of psychiatric symptom severity.
    Ross HE; Cutler M; Sklar SM
    Am J Addict; 1997; 6(4):293-303. PubMed ID: 9398927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alcohol, street drugs and therapeutic drugs in street traffic].
    Schöch H
    Fortschr Med; 1997 Mar; 115(7):39-42. PubMed ID: 9173020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal substance abuse in California: findings from the Perinatal Substance Exposure Study.
    Noble A; Vega WA; Kolody B; Porter P; Hwang J; Merk GA; Bole A
    J Psychoactive Drugs; 1997; 29(1):43-53. PubMed ID: 9110265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perinatal illicit drug use and fetal exposure: consequences and management with a public health approach.
    Oral R
    Drug Test Anal; 2009 Feb; 1(2):59-64. PubMed ID: 20355177
    [No Abstract]   [Full Text] [Related]  

  • 51. Dimensions of adolescent drug-avoidant attitude.
    Towberman DB; McDonald RM
    J Subst Abuse Treat; 1993; 10(1):45-52. PubMed ID: 8450572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing prevalence of prenatal substance abuse in Utah.
    Buchi KF; Zone S; Langheinrich K; Varner MW
    Obstet Gynecol; 2003 Jul; 102(1):27-30. PubMed ID: 12850602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substance abuse treatment services for pregnant women: psychosocial and behavioral approaches.
    Haug NA; Duffy M; McCaul ME
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):267-96. PubMed ID: 24845490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perinatal substance abuse and human subjects research: are privacy protections adequate?
    Marshall MF; Menikoff J; Paltrow LM
    Ment Retard Dev Disabil Res Rev; 2003; 9(1):54-9. PubMed ID: 12587139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pregnancy and substance dependency].
    Kraigher D; Schindler S; Ortner R; Fischer G
    Gesundheitswesen; 2001 Aug; 63 Suppl 2():S101-5. PubMed ID: 11533869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recent regulations on alcohol and other drugs in German criminal traffic law].
    Bode HJ
    Blutalkohol; 1994 May; 31(3):137-57. PubMed ID: 8049034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries.
    Humeniuk R; Ali R; Babor T; Souza-Formigoni ML; de Lacerda RB; Ling W; McRee B; Newcombe D; Pal H; Poznyak V; Simon S; Vendetti J
    Addiction; 2012 May; 107(5):957-66. PubMed ID: 22126102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Subutex is safe": perceptions of risk in using illicit drugs during pregnancy.
    Leppo A
    Int J Drug Policy; 2012 Sep; 23(5):365-73. PubMed ID: 22370011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Medicinal and illicit drug effects on automobile drivers in the Munster area 1980 to 1989. A retrospective study].
    Köhler-Schmidt H; Beschorner C
    Versicherungsmedizin; 1993 Feb; 45(1):17-20. PubMed ID: 8438536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.